ShareValue scores for 0G8X.LSE: Valuation 34, Quality 22, Growth 38, Health 43.
0G8X.LSELSE
Immunovia AB
£0.00
(+1.25%)
0G8X.LSELSE
Immunovia AB
£0.00(+1.25%)
Loading chart...
Sentiment
Verdicts
Value:Overvalued
Quality:Weak
Growth:Weak
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
-8% to 11%
Rating
Trap Risk
Return
-8% to 11%
Valuation
34
Overvalued
Price vs Value
Quality
22
Weak
Business Strength
Growth
38
Weak
Revenue & Earnings
Health
43
Moderate
Financial Stability
Momentum
48
Neutral
Price Trend
Company Details
About
Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Sector
IndustryN/A
ExchangeLSE
Market Cap$34,804.95
P/E RatioN/A
Dividend YieldNone
Sector Rank#2206
Score Analysis
AI Investment Thesis
Data as of:Aug 7, 2026
|Last calculated:Aug 7, 2026